67 FR 133 pg. 45981 - Advisory Committee; Renewals
Type: NOTICEVolume: 67Number: 133Page: 45981
FR document: [FR Doc. 02-17478 Filed 7-10-02; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committee; Renewals
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing the renewal of certain FDA advisory committees by the Deputy Commissioner of Food and Drugs (the Deputy Commissioner). The Deputy Commissioner has determined that it is in the public interest to renew the charters of the committees listed in the following table for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed in the following table. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Public Law 92-463 (5 U.S.C. app. 2)).
DATES:
Authority for these committees will expire on the dates indicated in the following table unless the Deputy Commissioner formally determines that renewal is in the public interest.
| Name of committee | Date of -expiration |
|---|---|
| Medical Imaging Drugs Advisory Committee | February 28, 2004 |
| Gastrointestinal Drugs Advisory Committee | March 3, 2004 |
| Advisory Committee for Reproductive Health Drugs | March 23, 2004 |
| Arthritis Advisory -Committee | April 5, 2004 |
| Veterinary Medicine -Advisory Committee | April 24, 2004 |
| Anesthetic and Life -Support Drugs -Advisory Committee | May 1, 2004 |
| Blood Products Advisory Committee | May 13, 2004 |
| Pulmonary-Allergy Drugs Advisory -Committee | May 30, 2004 |
| Drug Safety and Risk Management Advisory Committee (formerly Drug Abuse Advisory Committee) | May 31, 2004 |
| Science Advisory Board/NCTR | June 2, 2004 |
| Peripheral and Central Nervous System Drugs Advisory -Committee | June 4, 2004 |
| Psychopharmacologic Drugs Advisory -Committee | June 4, 2004 |
| Transmissible Spongiform Encephalopathies -Advisory Committee | June 9, 2004 |
FOR FURTHER INFORMATION CONTACT:
Linda A. Sherman, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.
Dated: July 5, 2002.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 02-17478 Filed 7-10-02; 8:45 am]
BILLING CODE 4160-01-S